IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel
FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed
Letter to the Editor: A Victory for Research, But Real Work Is Ahead
Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research
Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects
Funding Opportunities: RFA Available: Teams For Molecular Target Assessment
In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End
Trending Stories
- As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Ready or not, AI-based decision support tools are entering oncology clinics
Regulators and health systems must adapt - Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes
- A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline